Cargando…
Real-life measurement of size-fractionated aerosol concentration in a plethysmography box during the COVID-19 pandemic and estimation of the associated viral load
INTRODUCTION: There are concerns about pulmonary function tests (PFTs) being associated with aerosol generation and enhanced virus transmission. As a consequence, the number of PFTs was reduced significantly during the coronavirus disease 2019 pandemic. However, there are no robust data supporting t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414843/ https://www.ncbi.nlm.nih.gov/pubmed/34487775 http://dx.doi.org/10.1016/j.jhin.2021.08.025 |
_version_ | 1783747859245432832 |
---|---|
author | Tomisa, G. Horváth, A. Farkas, Á. Nagy, A. Kis, E. Tamási, L. |
author_facet | Tomisa, G. Horváth, A. Farkas, Á. Nagy, A. Kis, E. Tamási, L. |
author_sort | Tomisa, G. |
collection | PubMed |
description | INTRODUCTION: There are concerns about pulmonary function tests (PFTs) being associated with aerosol generation and enhanced virus transmission. As a consequence, the number of PFTs was reduced significantly during the coronavirus disease 2019 pandemic. However, there are no robust data supporting this fear. OBJECTIVES: To perform real-life measurement of aerosol concentrations in a PFT laboratory to monitor the concentration of particles near the patient, and to model the associated potential viral load. METHODS: Two optical particle counters were used to sample the background concentration and the concentration of particles near the patient's mouth in a whole-body plethysmography box. Statistical evaluation of the measured particle concentration time series was completed. The particle exhalation rate was assessed based on the measured particle concentration data by applying the near-field/far-field theory. The number of exhaled viruses by an infected patient during the test was compared with the emission of viruses during quiet breathing and speaking. RESULTS: Twenty-five patients were included in the study. Eighteen patients showed a significant increase in aerosol concentration [mean 1910 (standard deviation 593) particles/L]. Submicron particles dominated the number size distribution of the generated particles, but large particles represented a higher volume fraction in the generated particles compared with background. An average gene exhalation rate of 0.2/min was estimated from this data. This is one order of magnitude higher than the release rate for the same infected person during quiet breathing, and of the same order of magnitude as the release rate during normal speaking. CONCLUSIONS: This study demonstrated that PFTs are aerosol-generating procedures. Based on these results, the moderate increase in viral load does not underpin stopping such examinations. |
format | Online Article Text |
id | pubmed-8414843 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84148432021-09-03 Real-life measurement of size-fractionated aerosol concentration in a plethysmography box during the COVID-19 pandemic and estimation of the associated viral load Tomisa, G. Horváth, A. Farkas, Á. Nagy, A. Kis, E. Tamási, L. J Hosp Infect Article INTRODUCTION: There are concerns about pulmonary function tests (PFTs) being associated with aerosol generation and enhanced virus transmission. As a consequence, the number of PFTs was reduced significantly during the coronavirus disease 2019 pandemic. However, there are no robust data supporting this fear. OBJECTIVES: To perform real-life measurement of aerosol concentrations in a PFT laboratory to monitor the concentration of particles near the patient, and to model the associated potential viral load. METHODS: Two optical particle counters were used to sample the background concentration and the concentration of particles near the patient's mouth in a whole-body plethysmography box. Statistical evaluation of the measured particle concentration time series was completed. The particle exhalation rate was assessed based on the measured particle concentration data by applying the near-field/far-field theory. The number of exhaled viruses by an infected patient during the test was compared with the emission of viruses during quiet breathing and speaking. RESULTS: Twenty-five patients were included in the study. Eighteen patients showed a significant increase in aerosol concentration [mean 1910 (standard deviation 593) particles/L]. Submicron particles dominated the number size distribution of the generated particles, but large particles represented a higher volume fraction in the generated particles compared with background. An average gene exhalation rate of 0.2/min was estimated from this data. This is one order of magnitude higher than the release rate for the same infected person during quiet breathing, and of the same order of magnitude as the release rate during normal speaking. CONCLUSIONS: This study demonstrated that PFTs are aerosol-generating procedures. Based on these results, the moderate increase in viral load does not underpin stopping such examinations. The Authors. Published by Elsevier Ltd on behalf of The Healthcare Infection Society. 2021-12 2021-09-03 /pmc/articles/PMC8414843/ /pubmed/34487775 http://dx.doi.org/10.1016/j.jhin.2021.08.025 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Tomisa, G. Horváth, A. Farkas, Á. Nagy, A. Kis, E. Tamási, L. Real-life measurement of size-fractionated aerosol concentration in a plethysmography box during the COVID-19 pandemic and estimation of the associated viral load |
title | Real-life measurement of size-fractionated aerosol concentration in a plethysmography box during the COVID-19 pandemic and estimation of the associated viral load |
title_full | Real-life measurement of size-fractionated aerosol concentration in a plethysmography box during the COVID-19 pandemic and estimation of the associated viral load |
title_fullStr | Real-life measurement of size-fractionated aerosol concentration in a plethysmography box during the COVID-19 pandemic and estimation of the associated viral load |
title_full_unstemmed | Real-life measurement of size-fractionated aerosol concentration in a plethysmography box during the COVID-19 pandemic and estimation of the associated viral load |
title_short | Real-life measurement of size-fractionated aerosol concentration in a plethysmography box during the COVID-19 pandemic and estimation of the associated viral load |
title_sort | real-life measurement of size-fractionated aerosol concentration in a plethysmography box during the covid-19 pandemic and estimation of the associated viral load |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8414843/ https://www.ncbi.nlm.nih.gov/pubmed/34487775 http://dx.doi.org/10.1016/j.jhin.2021.08.025 |
work_keys_str_mv | AT tomisag reallifemeasurementofsizefractionatedaerosolconcentrationinaplethysmographyboxduringthecovid19pandemicandestimationoftheassociatedviralload AT horvatha reallifemeasurementofsizefractionatedaerosolconcentrationinaplethysmographyboxduringthecovid19pandemicandestimationoftheassociatedviralload AT farkasa reallifemeasurementofsizefractionatedaerosolconcentrationinaplethysmographyboxduringthecovid19pandemicandestimationoftheassociatedviralload AT nagya reallifemeasurementofsizefractionatedaerosolconcentrationinaplethysmographyboxduringthecovid19pandemicandestimationoftheassociatedviralload AT kise reallifemeasurementofsizefractionatedaerosolconcentrationinaplethysmographyboxduringthecovid19pandemicandestimationoftheassociatedviralload AT tamasil reallifemeasurementofsizefractionatedaerosolconcentrationinaplethysmographyboxduringthecovid19pandemicandestimationoftheassociatedviralload |